The 100 most-cited articles in castration-resistant prostate cancer: a bibliometric analysis
Purpose: To assess the present landscape and future research directions, a bibliometric analysis was performed to identify the characteristics of the 100 most-cited articles (T100 articles) on CRPC research. Methods: A list of the T100 articles investigating CRPC was generated by searching the W...
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MRE Press
2021-06-01
|
Series: | Journal of Men's Health |
Subjects: | |
Online Access: | https://article.imrpress.com/journal/JOMH/18/1/10.31083/jomh.2021.053/1875-6859-18-1-003.pdf |
_version_ | 1797326575172059136 |
---|---|
author | Hui Fang Lugeng He Huadong He Xuliang Wang Yuyong Wang Hongwei Ge Yuehua Wan Chao Chen |
author_facet | Hui Fang Lugeng He Huadong He Xuliang Wang Yuyong Wang Hongwei Ge Yuehua Wan Chao Chen |
author_sort | Hui Fang |
collection | DOAJ |
description | Purpose: To assess the present landscape and future research
directions, a bibliometric analysis was performed to identify the characteristics
of the 100 most-cited articles (T100 articles) on CRPC research.
Methods: A list of the T100 articles investigating CRPC was generated
by searching the Web of Science (WoS) Core Collection database. Different
characteristics of the T100 articles, including the countries/territories,
journals, authors, and research areas, were analyzed.
Results: The number of citations of T100 articles published between
1992 and 2017 ranged from 282 to 3594, with an average of 654.9 citations.
According to the topic of the article, “Mechanisms related to tumor progression
or metastasis” ranked first with 41 T100 articles, while immunotherapy ranked
fourth with 7 T100 articles. The T100 articles originated from 31 countries, with
more than half originating from the USA (n = 89). Professor Scher HI published
the most T100 articles as the first author (4) and as the corresponding author
(5), while Pro De Bono JS from the Institute of Cancer Research published 3
articles as the first author and 8 articles as the corresponding author. The
journal Cancer Research published 20 T100 articles with a total of 8946
citations. The number of T100 articles (r = 0.485, P = 0.01) and the
total number of citations (r = 0.626, P < 0.001) were all positively
correlated with the IF of the journal.
Conclusions: This analysis offers a historical perspective on the
progress and attempts to reveal future trends in CRPC research using bibliometric
analysis. This study’s results suggest that immunotherapy and the study of
androgen receptors as well as their signaling axes will possibly be hot topics
and trends in CRPC research. |
first_indexed | 2024-03-08T06:26:12Z |
format | Article |
id | doaj.art-4d9fd6f94aaa4583afb822457c75e95d |
institution | Directory Open Access Journal |
issn | 1875-6859 |
language | English |
last_indexed | 2024-03-08T06:26:12Z |
publishDate | 2021-06-01 |
publisher | MRE Press |
record_format | Article |
series | Journal of Men's Health |
spelling | doaj.art-4d9fd6f94aaa4583afb822457c75e95d2024-02-03T14:45:07ZengMRE PressJournal of Men's Health1875-68592021-06-0118100310.31083/jomh.2021.053S1875-6867(21)00236-0The 100 most-cited articles in castration-resistant prostate cancer: a bibliometric analysisHui Fang0Lugeng He1Huadong He2Xuliang Wang3Yuyong Wang4Hongwei Ge5Yuehua Wan6Chao Chen7Institute of Information Resource, Zhejiang University of Technology, 310014 Hangzhou, Zhejiang, ChinaDepartment of Urology, Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine, 310006 Hangzhou, Zhejiang, ChinaDepartment of Urology, Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine, 310006 Hangzhou, Zhejiang, ChinaDepartment of Urology, Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine, 310006 Hangzhou, Zhejiang, ChinaDepartment of Urology, Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine, 310006 Hangzhou, Zhejiang, ChinaDepartment of Urology, Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine, 310006 Hangzhou, Zhejiang, ChinaInstitute of Information Resource, Zhejiang University of Technology, 310014 Hangzhou, Zhejiang, ChinaDepartment of Urology, Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine, 310006 Hangzhou, Zhejiang, ChinaPurpose: To assess the present landscape and future research directions, a bibliometric analysis was performed to identify the characteristics of the 100 most-cited articles (T100 articles) on CRPC research. Methods: A list of the T100 articles investigating CRPC was generated by searching the Web of Science (WoS) Core Collection database. Different characteristics of the T100 articles, including the countries/territories, journals, authors, and research areas, were analyzed. Results: The number of citations of T100 articles published between 1992 and 2017 ranged from 282 to 3594, with an average of 654.9 citations. According to the topic of the article, “Mechanisms related to tumor progression or metastasis” ranked first with 41 T100 articles, while immunotherapy ranked fourth with 7 T100 articles. The T100 articles originated from 31 countries, with more than half originating from the USA (n = 89). Professor Scher HI published the most T100 articles as the first author (4) and as the corresponding author (5), while Pro De Bono JS from the Institute of Cancer Research published 3 articles as the first author and 8 articles as the corresponding author. The journal Cancer Research published 20 T100 articles with a total of 8946 citations. The number of T100 articles (r = 0.485, P = 0.01) and the total number of citations (r = 0.626, P < 0.001) were all positively correlated with the IF of the journal. Conclusions: This analysis offers a historical perspective on the progress and attempts to reveal future trends in CRPC research using bibliometric analysis. This study’s results suggest that immunotherapy and the study of androgen receptors as well as their signaling axes will possibly be hot topics and trends in CRPC research.https://article.imrpress.com/journal/JOMH/18/1/10.31083/jomh.2021.053/1875-6859-18-1-003.pdfcastration-resistant prostate cancer (crpc)mechanismtumor progressionmetastasisimmunotherapybibliometric analysis |
spellingShingle | Hui Fang Lugeng He Huadong He Xuliang Wang Yuyong Wang Hongwei Ge Yuehua Wan Chao Chen The 100 most-cited articles in castration-resistant prostate cancer: a bibliometric analysis Journal of Men's Health castration-resistant prostate cancer (crpc) mechanism tumor progression metastasis immunotherapy bibliometric analysis |
title | The 100 most-cited articles in castration-resistant prostate cancer: a bibliometric analysis |
title_full | The 100 most-cited articles in castration-resistant prostate cancer: a bibliometric analysis |
title_fullStr | The 100 most-cited articles in castration-resistant prostate cancer: a bibliometric analysis |
title_full_unstemmed | The 100 most-cited articles in castration-resistant prostate cancer: a bibliometric analysis |
title_short | The 100 most-cited articles in castration-resistant prostate cancer: a bibliometric analysis |
title_sort | 100 most cited articles in castration resistant prostate cancer a bibliometric analysis |
topic | castration-resistant prostate cancer (crpc) mechanism tumor progression metastasis immunotherapy bibliometric analysis |
url | https://article.imrpress.com/journal/JOMH/18/1/10.31083/jomh.2021.053/1875-6859-18-1-003.pdf |
work_keys_str_mv | AT huifang the100mostcitedarticlesincastrationresistantprostatecancerabibliometricanalysis AT lugenghe the100mostcitedarticlesincastrationresistantprostatecancerabibliometricanalysis AT huadonghe the100mostcitedarticlesincastrationresistantprostatecancerabibliometricanalysis AT xuliangwang the100mostcitedarticlesincastrationresistantprostatecancerabibliometricanalysis AT yuyongwang the100mostcitedarticlesincastrationresistantprostatecancerabibliometricanalysis AT hongweige the100mostcitedarticlesincastrationresistantprostatecancerabibliometricanalysis AT yuehuawan the100mostcitedarticlesincastrationresistantprostatecancerabibliometricanalysis AT chaochen the100mostcitedarticlesincastrationresistantprostatecancerabibliometricanalysis AT huifang 100mostcitedarticlesincastrationresistantprostatecancerabibliometricanalysis AT lugenghe 100mostcitedarticlesincastrationresistantprostatecancerabibliometricanalysis AT huadonghe 100mostcitedarticlesincastrationresistantprostatecancerabibliometricanalysis AT xuliangwang 100mostcitedarticlesincastrationresistantprostatecancerabibliometricanalysis AT yuyongwang 100mostcitedarticlesincastrationresistantprostatecancerabibliometricanalysis AT hongweige 100mostcitedarticlesincastrationresistantprostatecancerabibliometricanalysis AT yuehuawan 100mostcitedarticlesincastrationresistantprostatecancerabibliometricanalysis AT chaochen 100mostcitedarticlesincastrationresistantprostatecancerabibliometricanalysis |